Ticker Details
Enliven Therapeutics, Inc.
IPO Date:	February 24, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.53B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.66 | 3.19%
Avg Daily Range (30 D):	$0.98 | 2.27%
Avg Daily Range (90 D):	$1.01 | 2.96%

Institutional Daily Volume
Avg Daily Volume:	.33M
Avg Daily Volume (30 D):	.64M
Avg Daily Volume (90 D):	.88M

Trade Size
Avg Trade Size (Sh.):	70
Avg Trade Size (Sh.) (30 D):	56
Avg Trade Size (Sh.) (90 D):	68

Institutional Trades
Total Institutional Trades:	1,153
Avg Institutional Trade:	$1.62M
Avg Institutional Trade (30 D):	$2.19M
Avg Institutional Trade (90 D):	$1.96M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$1.71M
Avg Closing Trade (30 D):	$2.93M
Avg Closing Trade (90 D):	$2.76M
Avg Closing Volume:	71.14K

News

Aug 13, 2025 @ 10:15 PM Enliven Posts Loss Beat and Cash Surge Source: Jesterai

Oct 14, 2024 @ 7:05 PM Enliven Therapeutics, Inc. Is a Great Choice for '... Source: Zacks

Sep 28, 2024 @ 1:35 PM Enliven Therapeutics Announces Positive Data Updat... Source: N/A

Jul 16, 2024 @ 10:44 PM Enliven Therapeutics COO sells over $1.25m in comp... Source: Investing.Com

May 29, 2024 @ 8:05 PM Enliven Therapeutics to Present at Two Upcoming In... Source: Enliven Therapeutics, Inc.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.38	$-.48	$-1.83
Diluted EPS	$-.38	$-.48	$-1.83
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-23.63M	$-29.67M	$-103.69M
Operating Income / Loss	$-27.82M	$-34.29M	$-119.66M
Cost of Revenue
Net Cash Flow	$33.29M	$-2.84M	$-25.28M
PE Ratio